The USA remains the key contributor due to its advanced healthcare infrastructure, increasing investments in medical research, and the presence of major pharmaceutical and biopharmaceutical companies.
The global polyclonal antibody market is poised for significant expansion in the coming decade, driven by increasing ...
BACKGROUND: Despite the high morbidity and mortality of heart failure with preserved ejection fraction (HFpEF), treatment ...
The united states protein a resins market is projected to maintain its position as a high-volume sector through 2035, with steady growth driven by increasing demand in biopharmaceutical manufacturing ...
The intrinsic factor of cell senescence, PCBP2, was identified by unlabeled quantitative proteomics, and its biological role in in vitro replication senescence of human bone marrow mesenchymal stromal ...
Please view our affiliate disclosure. Trading involves risk which may result in the loss of capital. Kadena (KDA) is an enterprise-grade, interwoven blockchain ecosystem. The protocol integrates a ...
LKM-1 50 Cytochrome P450 2D6 Autoimmune hepatitis Type 2 hepatitis C LKM-2 50 Cytochrome P450 2C9 Ticrynafen-induced hepatitis ...
What makes your blood different from someone else’s is your unique combination of protein molecules, called antigens and antibodies. Antigens live on the surface of your red blood cells.
AIH type 3 is serologically defined by the presence of SLA/LP autoantibodies. However, 74% of patients also have other serological markers of autoimmunity, including SMA and AMA. AIH type 3 has a ...
Derived from scRNA-seq, SLC26A3 is a potential therapeutic target to improve the efficacy of immunotherapy, as well as a potential diagnostic indicator to reduce post-surgical upstaging, for cervical ...
The following primary antibodies were used: PRMT5 (Abcam), PD-L1 (CST), STAT1 (CST), sDMR (Abcam), and actin (ABclonal). The membranes were incubated with secondary antibodies (Abcam), and the protein ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results